Yissum licenses regenerative medicine technologies to TheraCell
This article was originally published in Scrip
Executive Summary
Yissum, the technology transfer arm of the Hebrew University of Jerusalem, has licensed a package of stem cell-related technologies to TheraCell which intends to further develop and commercialise them for advanced regenerative medicine procedures such as spinal fusion.